secwatch.observer — SEC 8-K summary
======================================

Issuer:     HealthLynked Corp (HLYK)
CIK:        0001680139
Form:       8-K
Filed at:   2025-01-15T23:59:59+00:00
Accession:  0001213900-25-003828
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HealthLynked appoints Jeremy Daniel as part-time CFO; David Rosal resigns
-------------------------------------------------------------------------

- Jeremy Daniel appointed CFO effective Jan 15, 2025; replaces David Rosal who resigned without disagreement.
- Daniel works two days per week at $66K annual salary; also serves as CFO of Innoveren Scientific since 2019.
- Daniel previously CFO at Regenerative Medicine Solutions (2013-19) and controller at Omnicare (2012-14).
- Daniel holds MBA from Xavier University, BBA in Accounting from University of Cincinnati, and is a CPA.
- CEO Michael Dent cited Daniel's experience in financial operations and strategic planning as key to appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680139/000121390025003828/0001213900-25-003828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680139/000121390025003828/ea0227787-8k_health.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-003828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer